Adjuvant postoperative high-dose radiotherapy for atypical and malignant meningioma: A phase-II parallel non-randomized and observation study (EORTC 22042-26042)

Damien C. Weber, Carmen Ares, Salvador Villa, Saskia M. Peerdeman, Laurette Renard, Brigitta G. Baumert, Anna Lucas, Theo Veninga, Alessia Pica, Sarah Jefferies, Umberto Ricardi, Raymond Miralbell, Jean-Jacques Stelmes, Yan Liu, Laurence Collette, Sandra Collette

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)260-265
Number of pages6
JournalRadiotherapy and Oncology
Volume128
Issue number2
DOIs
Publication statusPublished - 1 Aug 2018

Keywords

  • Atypical meningioma
  • Malignant meningioma
  • Phase II trial
  • Observational study
  • Radiotherapy
  • Dose escalation
  • EVIDENCE-BASED MEDICINE
  • INTRACRANIAL MENINGIOMA
  • RETROSPECTIVE ANALYSIS
  • SURGICAL RESECTION
  • RADIATION-THERAPY
  • QUALITY-ASSURANCE
  • CLINICAL ARTICLE
  • TRIAL
  • CLASSIFICATION
  • IRRADIATION

Cite this

Weber, D. C., Ares, C., Villa, S., Peerdeman, S. M., Renard, L., Baumert, B. G., Lucas, A., Veninga, T., Pica, A., Jefferies, S., Ricardi, U., Miralbell, R., Stelmes, J-J., Liu, Y., Collette, L., & Collette, S. (2018). Adjuvant postoperative high-dose radiotherapy for atypical and malignant meningioma: A phase-II parallel non-randomized and observation study (EORTC 22042-26042). Radiotherapy and Oncology, 128(2), 260-265. https://doi.org/10.1016/j.radonc.2018.06.018